77 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
to a YOFOTO-owned Canadian subsidiary, with detailed assignment reversion rights upon failure to meet defined targets. At the date of these financial
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
scheduled milestone payments. Should it be deemed not to be YOFOTO's fault in not meeting its milestone targets, the Company may have the risk of having
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
targets. At the date of these financial statements, no such Chinese patents have been assigned to YOFOTO.
On October 9, 2018, the $5,090,005 private
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
RepliCel not to receive its scheduled milestone payments. Should it be deemed not to be YOFOTO's fault in not meeting its milestone targets, the Company may
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
causing RepliCel not to receive its scheduled milestone payments. Should it be deemed not to be YOFOTO's fault in not meeting its milestone targets
6-K
EX-99.1
oi41cldnfnor8pfkeeuq
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.2
9v9599
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
9brszgs6aq4b8p62yr7
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
0vgnfctqcdy by
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
9n8398vaqlp1hbr8
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
3qinx9
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.3
k24voabrip7u4
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.4
q56zh0
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.1
5z8fyf9
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
2ztod1xa qpp2w
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
o6i7fkx
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.1
00k75x3 7pynzx0e9c
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.1
jy8af8ybmayd62e
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am